AVI-6003
- Generic Name
- AVI-6003
Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
- First Posted Date
- 2011-05-12
- Last Posted Date
- 2012-05-07
- Lead Sponsor
- Sarepta Therapeutics, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01353040
- Locations
- 🇺🇸
West Coast Clinical Trials, Cypress, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath